Fentanyl vs dexmedetomidine nebulization as adjuvant to lignocaine: A comparative study during awake flexible fiberoptic bronchoscopy

Abstract

Background and aimsFlexible fiberoptic bronchoscopy is used to diagnose diseases of the tracheobronchial tree and to obtain samples. Methods used for awake flexible fiberoptic bronchoscopy (FFB) to anaesthetize the airway include local anaesthetic nebulization, gargles, lozenges, sprays, and airway blocks. The aim is to compare the effect of fentanyl and dexmedetomidine nebulization as an adjuvant to lignocaine during awake FFB. MethodsNinety patients were recruited and were randomized into 3 groups. Group I Patients were nebulised with a mixture of 4% lignocaine 4 ml and fentanyl 2 μg/kg, Group II with a mixture of 4% lignocaine 4 ml and dexmedetomidine 1 μg/kg, and Group III with 4% lignocaine 4 ml and saline. ResultsCough score was lower in Group II (1.6 ± 0.67) than Group I (2.5 ± 0.68) and Group III (2.7 ± 0.59). This difference between Group II and the rest of the group was highly significant (P < 0.001). Patients of Group II also had better satisfaction scores (1.40 ± 0.56) when compared to Group I (1.90 ± 0.71) and Group III (2.43 ± 0.57). Patients in Group II were more comfortable (1.23 ± 0.43) than Group I (1.63 ± 0.49) and Group III (1.87 ± 0.34) (P < 0.001). ConclusionDexmedetomidine as an adjuvant to lignocaine nebulization provides a better condition for bronchoscopy than fentanyl or lignocaine alone.